110 related articles for article (PubMed ID: 29110537)
1. Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy.
Thysiadis S; Katsamakas S; Dalezis P; Chatzisideri T; Trafalis D; Sarli V
Future Med Chem; 2017 Dec; 9(18):2181-2196. PubMed ID: 29110537
[TBL] [Abstract][Full Text] [Related]
2. Discovery of steroidal lactam conjugates of POPAM-NH
Trafalis D; Dalezis P; Geromichalou E; Sagredou S; Sflakidou E; Voura M; Grammatikopoulou M; Gabriel C; Sarli V
Future Med Chem; 2020 Jan; 12(1):19-35. PubMed ID: 31729254
[No Abstract] [Full Text] [Related]
3. Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins.
Chatzisideri T; Dalezis P; Leonidis G; Bousis S; Trafalis D; Bianchini F; Sarli V
Future Med Chem; 2021 May; 13(10):877-895. PubMed ID: 33858195
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
Chatzisideri T; Thysiadis S; Katsamakas S; Dalezis P; Sigala I; Lazarides T; Nikolakaki E; Trafalis D; Gederaas OA; Lindgren M; Sarli V
Eur J Med Chem; 2017 Dec; 141():221-231. PubMed ID: 29031069
[TBL] [Abstract][Full Text] [Related]
5. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
[TBL] [Abstract][Full Text] [Related]
6. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
7. RGD-mediated delivery of small-molecule drugs.
Katsamakas S; Chatzisideri T; Thysiadis S; Sarli V
Future Med Chem; 2017 Apr; 9(6):579-604. PubMed ID: 28394627
[TBL] [Abstract][Full Text] [Related]
8. Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine.
Chatzisideri T; Leonidis G; Karampelas T; Skavatsou E; Velentza-Almpani A; Bianchini F; Tamvakopoulos C; Sarli V
J Med Chem; 2022 Jan; 65(1):271-284. PubMed ID: 34967607
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery.
Chen X; Plasencia C; Hou Y; Neamati N
J Med Chem; 2005 Feb; 48(4):1098-106. PubMed ID: 15715477
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of new steroidal lactam conjugates with aniline mustards as potential antileukemic therapeutics.
Trafalis D; Geromichalou E; Dalezis P; Nikoleousakos N; Sarli V
Steroids; 2016 Nov; 115():1-8. PubMed ID: 27473822
[TBL] [Abstract][Full Text] [Related]
13. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
Arosio D; Manzoni L; Corno C; Perego P
Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
[TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
15. Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.
Sheldrake HM; Patterson LH
J Med Chem; 2014 Aug; 57(15):6301-15. PubMed ID: 24568695
[TBL] [Abstract][Full Text] [Related]
16. Proteomics analysis of a novel compound: cyclic RGD in breast carcinoma cell line MCF-7.
Juan HF; Wang IH; Huang TC; Li JJ; Chen ST; Huang HC
Proteomics; 2006 May; 6(10):2991-3000. PubMed ID: 16619296
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of PEGylated fullerene-5-fluorouracil conjugates to enhance the antitumor effect of 5-fluorouracil.
Dou Z; Xu Y; Sun H; Liu Y
Nanoscale; 2012 Aug; 4(15):4624-30. PubMed ID: 22706520
[TBL] [Abstract][Full Text] [Related]
18. Novel 99mTc '4 + 1' peptide conjugates: tuning the biodistribution by variation of coligands.
Kunstler JU; Seidel G; Bergmann R; Gniazdowska E; Walther M; Schiller E; Decristoforo C; Stephan H; Haubner R; Steinbach J; Pietzsch HJ
Eur J Med Chem; 2010 Sep; 45(9):3645-55. PubMed ID: 20570022
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
